FDA-Approved PanOptix and Constelation Reach 3,000 Cases Each... Alcon Awards 'Certification Plaque'

From the left, Director Song Yong-ju, Director Kim Geun-oh, Director Ban Tae-su, and Chief Director Yoon Gil-jung of Bright Eye Clinic 21. President Choi Jun-ho, Director Kim Deok-bae, Director Kim Ju-yeop, and Director Jung Moo-oh of Alcon Korea are taking a commemorative photo after the certificate presentation ceremony. Photo by Bright Eye Clinic 21

From the left, Director Song Yong-ju, Director Kim Geun-oh, Director Ban Tae-su, and Chief Director Yoon Gil-jung of Bright Eye Clinic 21. President Choi Jun-ho, Director Kim Deok-bae, Director Kim Ju-yeop, and Director Jung Moo-oh of Alcon Korea are taking a commemorative photo after the certificate presentation ceremony. Photo by Bright Eye Clinic 21

View original image

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Bright Eye Clinic 21 Hospital, celebrating its 22nd anniversary, has proven itself as the leading ophthalmology hospital representing Gwangju and Jeonnam in cataract multifocal intraocular lens surgery. Additionally, the successful outcomes of vitrectomy have been recognized for their outstanding technical skills and surgical expertise.


Bright Eye Clinic 21 Hospital announced on the 15th that it received a certification plaque from Alcon, a global ophthalmic medical device specialist company, for achieving '3,000 cataract surgeries using PanOptix' and '3,000 cases of Constellation vitrectomy.'


Alcon's PanOptix is an intraocular lens developed by the American company Alcon, approved by the U.S. FDA, and is a multifocal intraocular lens implanted during cataract surgery.


Based on a quad-focus design, PanOptix can simultaneously correct presbyopia and cataracts, providing a visual range from 40 to 80 cm, allowing clear vision at near, intermediate, and far distances.


It is also made of a biocompatible (hydrophobic) material, ensuring safe vision, and the lens does not contract after implantation, offering excellent fixation.


This multifocal intraocular lens is optimized for middle-aged and older adults who engage in many outdoor activities and near work.


Alcon's Constellation is an advanced retinal surgery device approved by the U.S. FDA, used for the highly challenging vitrectomy procedure.


This equipment features a 5,000 cpm ultra-high-speed vitrectomy function, reducing surgery time and enabling various retinal surgeries. Therefore, it minimizes vision loss due to complications and achieves satisfactory surgical outcomes.


CEO Yoon Giljung stated, “Cataracts can be treated with various intraocular lenses tailored to each patient's lifestyle, and the use of cutting-edge equipment has enhanced surgical safety and accuracy. We will continue to do our best to provide safe and clear vision to many patients, repaying their long-standing trust.”


Meanwhile, Bright Eye Clinic 21 Hospital has been designated as an ophthalmology specialty hospital by the Ministry of Health and Welfare for four consecutive times and has obtained certification as a medical institution from the Ministry of Health and Welfare three times in a row, establishing itself as an excellent medical institution where patients can receive treatment with confidence. On this day, marking its 22nd anniversary, the hospital also held a small commemorative ceremony on-site.





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing